Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,700
+1,200 (1.92%)
At close: Apr 27, 2026
47.80%
Market Cap 497.98B
Revenue (ttm) 16.48B
Net Income (ttm) -311.08M
Shares Out 8.20M
EPS (ttm) -38.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 56,329
Average Volume 87,626
Open 62,400
Previous Close 62,500
Day's Range 61,600 - 64,000
52-Week Range 38,300 - 101,000
Beta n/a
RSI 40.41
Earnings Date Mar 27, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.